April 13, 2017 - Ottawa, ON – Philippe Lucas, Executive Director of the Canadian Medical Cannabis Council
(CMCC) CMCC today released the following statement regarding the release of the proposed cannabis legislation: “We applaud the federal government for its announcement today that protects the medical cannabis market as regulated through the Access to Cannabis for Medical Purposes Regulations (ACMPR) and ensures patients have access to a secure, stable medical cannabis system.”
“It is vital that public and private drug insurance providers work to provide coverage for medical cannabis in a manner consistent with other medical products.” Though the taxation system on the recreational market is still to be determined, Lucas stressed the importance for patients to access medical cannabis tax-free, in the same manner patients access other pharmaceuticals: “The federal, provincial and territorial governments, as well as private insurance providers, have an opportunity to rectify the current disadvantage faced by medical cannabis patients. Medical cannabis must be treated consistently with other pharmaceutical products, and must be zero-rated”.
CMCC looks forward to partnering with the federal government as it adapts the medical cannabis regulatory framework while ensuring patient safety and access in a system that remains distinct and separate from the recreational market.
The CMCC represents stakeholders who are committed to advancing the highest standards of integrity, safety, quality, access, security and research within Canada’s medical cannabis industry. Members of CMCC have created, and abide by, the world’s first professional Code of Ethics designed to serve the best interests of medical cannabis patients. CMCC is committed to serving the needs of patients and works closely with its internal Patient Advisory Council.
For more information please contact:
Pomp & Circumstance PR